Review of OxLDL Driven Inflammatory Cell Activation

Area of Science:

• Cardiovascular Research
• Immunology
• Molecular Biology

Background:

• Atherosclerosis is characterized by inflammation within artery plaques, involving macrophages and T-cells.
• Oxidized low-density lipoprotein (oxLDL) is abundant in plaques, suggesting a role in inflammation.
• Understanding oxLDL's inflammatory effects is crucial for developing targeted therapies.

Purpose of the Study:

• To systematically review the inflammatory effects of oxLDL on vascular cells.
• To evaluate therapeutic strategies for preventing oxLDL-induced inflammation.
• To identify gaps in current research regarding oxLDL and atherosclerosis.

Main Methods:

• Systematic literature search of PubMed, Medline, and Scopus databases.
• Inclusion criteria focused on studies of oxLDL's inflammatory effects and anti-inflammatory treatments in humans or human cell lines.
• Full-text review of selected articles to assess study suitability.

Main Results:

• Eight studies confirmed oxLDL's inflammatory effects, showing increased levels of interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α.
• OxLDL stimulation led to increased caspase-1 activation in some studies.
• While some anti-inflammatory agents showed efficacy, none directly targeted oxLDL's immune activation pathways.
• A discrepancy exists between the proposed role of oxLDL and its demonstrated intrinsic effects on vascular cells.

Conclusions:

• Oxidized low-density lipoprotein (oxLDL) significantly contributes to vascular inflammation by upregulating key inflammatory cytokines.
• Current anti-inflammatory therapies lack direct targeting of oxLDL-mediated immune responses.
• Further research is needed to bridge the gap between suggested and intrinsic inflammatory roles of oxLDL in atherosclerosis pathogenesis.